Bristol researcher awarded over £850,000 to develop new treatments for autoimmune diseases
A University of Bristol project aiming to develop next-generation therapeutics for autoimmune diseases has received over £850,000 in new funding through the beLAB1407 BRIDGE partnership, supported by Evotec and its global pharmaceutical collaborators.









